Light and shade in Q2 results Reig Jofre''s Q2 results saw some positive surprises, such as the strong recovery in pharma specialities (+17% vs Q2 20) thanks to the return to more normalised levels of derma and osteoarticular patients, and the good evolution in some consumer healthcare products (vitamins). On the negative side the company suffered a headwind in pharma technologies (-13% vs Q2 20) due to lower ''essential medicines'', including antibiotics. Additionally, contrary to our initial ....